Corporate Governance

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment


The company’s auditor is appointed by the Annual General Meeting (AGM) for the period until the end of the next AGM. At the AGM 2023, until the end of the AGM 2024, the registered audit firm Öhrlings PricewaterhouseCoopers AB (PwC) was elected as auditor.

Leonard Daun is the auditor in charge.

The auditor reviews the accounts of the parent company and the group on behalf of the AGM. The external auditing of the parent company and the group’s accounts, as well as of the Board and CEO’s management, are conducted in accordance with generally accepted auditing standards in Sweden.

The auditor can be reached via Öhrlings PricewaterhouseCoopers, Vaksalagatan 6, 753 20 Uppsala, Sweden.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10